We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

REMSleep Holdings Inc

Company price
0.0013 USD -0.00 ( 7.14%)
Last update at 2026-11-12T14:34:00Z
VOLUME
310000
Market Cap
2.78M

Momentum Score

…

REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
0.01M
Revenue Per Share
-
Gross Profit TTM
-0.00M
Debt / Equity
2.45
ROE
-5012.65%
Net Debt
-214513.92M
ROCE
-6562.27%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -3.02M -1.08M -1.78M -1.49M -3.83M
Net income -3020300.00M -1.08M -1.78M -1.52M -4.74M
Selling general administrative 467627.00M 0.62M 0.72M 0.95M 0.30M
Selling and marketing expenses - 384235.38M 0.14M - -
Gross profit -0.03M 0.02M -0.76M 0.07M -
Reconciled depreciation 0.04M 0.07M 0.10M 0.06M 0.06M
Ebit -2.63M -0.93M -1.77M -1.22M -0.43M
Ebitda -2.60M -0.86M -1.67M -1.16M -1.09M
Depreciation and amortization 0.04M 0.07M 0.10M 0.06M -0.66M
Operating income -2.77M -0.79M -1.77M -1.22M -0.43M
Other operating expenses 2.78M 0.91M 1.98M 1.54M 0.43M
Interest expense 0.39M 0.14M 0.01M 0.24M 0.92M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -0.39M -0.14M -0.01M -0.24M -1.64M
Income tax expense - - - 0.03M 0.92M
Total revenue 0.02M 0.12M 0.20M 0.32M 0.00M
Total operating expenses 2.74M 0.81M 1.01M 1.29M 0.43M
Cost of revenue 0.05M 0.10M 0.96M 0.25M -
Total other income expense net -0.25M -0.28M -0.01M -0.27M -3.40M
Net income from continuing ops -3.02M -1.08M -1.78M -1.49M -3.83M
Net income applicable to common shares - - - -2.02M -3.83M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.34M 0.59M 1.21M 3.36M 3.50M
Other current assets -260817.73M 0.01M 0.01M - -
Total liab 0.31M 0.25M 0.28M 0.65M 0.88M
Total stockholder equity 0.03M 336703.00M 0.93M 2.71M 2.62M
Other current liab 0.11M 0.15M 0.06M 0.15M 0.29M
Common stock 1.66M 1.52M 1.46M 1.46M 1.23M
Capital stock 1.67M 1.53M 1.47M 1.47M 1.24M
Retained earnings -18.29M -15.27M -14.19M -12.41M -10.39M
Other assets - - - 0.01M 0.01M
Cash 214514.00M 0.46M 0.72M 1.84M 3.38M
Total current liabilities 0.30M 0.25M 0.23M 0.47M 0.88M
Current deferred revenue - - - - 0.16M
Net debt -214513.92M -0.44M -0.54M -1.39M -2.97M
Short term debt 0.07M 0.03M 0.13M 0.27M 0.42M
Short long term debt 0.05M 0.02M - 0.18M 0.42M
Short long term debt total 0.08M 0.03M 0.18M 0.45M 0.42M
Other stockholder equity 16.75M 14.08M 13.75M 13.66M 11.77M
Property plant equipment - - - 0.44M 0.11M
Total current assets 0.27M 0.49M 0.84M 2.91M 3.38M
Net tangible assets - - - 2.70M 2.61M
Short term investments - 463342.54M - - -
Net receivables 0.00M 0.00M 0.01M 0.01M -
Inventory 46304.00M 9050.00M 0.10M 1.06M 0.00M
Accounts payable 0.11M 0.03M 0.04M 0.05M 0.02M
Accumulated other comprehensive income -0.09M - -0.09M - -
Non currrent assets other -64562.93M 0.01M 0.01M 0.01M 0.01M
Non current assets total 0.07M 0.10M 0.37M 0.45M 0.12M
Capital lease obligations 0.03M 0.01M 0.18M 0.27M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.12M -0.15M -0.12M -0.07M
Change to liabilities - - - 0.04M -0.00M
Total cashflows from investing activities - -0.12M -0.15M -0.12M -0.07M
Net borrowings 0.25M 0.13M -0.18M -0.04M 0.58M
Total cash from financing activities 254000.00M 0.55M -0.18M 0.81M 3.69M
Change to operating activities - - - -0.03M 0.12M
Net income -3020300.00M -1.08M -1.78M -1.49M -3.83M
Change in cash -248829.00M -0.26M -1.12M -1.54M 3.27M
Begin period cash flow 463343.00M 0.72M 1.84M 3.38M 0.11M
End period cash flow 214514.00M 0.46M 0.72M 1.84M 3.38M
Total cash from operating activities -502829.00M -0.68M -0.79M -2.23M -0.35M
Issuance of capital stock 0.00M 0.42M 0.00M 0.85M 3.10M
Depreciation 35453.00M 0.07M 0.10M 0.06M 0.06M
Other cashflows from investing activities - -124699.88M - - -
Change to inventory -0.04M 0.10M 0.22M -1.06M 0.01M
Change to account receivables 0.00M 0.00M 0.00M -0.01M 0.10M
Other cashflows from financing activities 253999.75M 551999.45M - 0.00M 0.59M
Change to netincome - - - 0.05M 2.48M
Capital expenditures 0.00M 0.12M 0.15M 0.12M 0.07M
Change in working capital 0.08M 0.07M 0.11M -1.06M 0.12M
Stock based compensation 7500.00M -7500.00M - 5000.00M 12000.00M
Other non cash items 2474517.92M 7500.25M 0.77M -4999.75M 3.30M
Free cash flow -502829.00M -0.81M -0.94M -2.36M -0.42M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RMSL
REMSleep Holdings Inc
-0.00
7.14%
0.00 - - 233.96 235.09 247.97 -17.07
ABT
Abbott Laboratories
-0.71
0.65%
108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
0.28
0.28%
101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-2.16
0.68%
316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-
-%
47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

REMSleep Holdings Inc

REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.

3222 HWY 84, Blackshear, GA, United States, 31516

902 590 2001

2

Name Title Year Born
Mr. Russell F. Bird Founder, Pres & Chairman 1949
Mr. Thomas J. Wood Founder, CEO, CFO, Sec., Designer & Director 1946
Mr. Jonathan B. Lane VP & CTO 1960
Mr. Thomas J. Wood Founder, CEO, President, Secretary & Director 1946
Ms. Teresita Rubio Treasurer & Chairman NA
Dr. Sanja Pekovic Ph.D. Chief Executive Officer 1955
Peter Downey Interim President NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…